Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

More children suffering from type 2 diabetes in England and Wales

August 20, 2018 Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people

The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …
News

Chinese regulators approve Roche’s Alecensa in regulatory shift

August 20, 2018 Sales and Marketing Cancer, China, Roche, approval, lung cancer

China’s National Drug Administration has granted rapid approval for Roche’s lung cancer treatment Alecensa (alectinib). Chinese regulators have in the …
News
andrew_cheng

Gilead CMO announces departure alongside two new exec appointments

August 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …
Appointment
hero-plus

FDA approves first-ever generic EpiPen versions, courtesy of Teva

August 17, 2018 Medical Communications, Sales and Marketing FDA, Mylan, Teva, US, epipen, pharma

The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, Litigation, OxyContin, Purdue Pharma, approvals, top 10

This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue …
News
biogen_austria_238

NICE rejects Biogen’s spinal muscular dystrophy drug Spinraza after long delay

August 14, 2018 Manufacturing and Production, Sales and Marketing Biogen, NICE, Spinraza, UK, pharma, spinal muscular dystrophy

UK watchdog NICE has rejected Biogen’s spinal muscular dystrophy drug Spinraza (nusinersen) over cost concerns, denying patients the only available …
News
nawal_ouzren_-_sensorion_alt

Working Life: Nawal Ouzren, CEO of Sensorion

August 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma

Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …
Feature
chris-collins_getty_images

Indicted GOP congressman Chris Collins’ terminates re-election campaign

August 13, 2018 Medical Communications, Sales and Marketing Chris Collins, Innate Therapeutics, US, pharma

Indicted republican congressman Chris Collins has performed a U-turn since his arrest on Wednesday under allegations of insider trading, confirming …
News

Astellas acquires gene therapy group Quethera in £85 million deal

August 13, 2018 Sales and Marketing Astellas, Japan, gene therapy, ocular, quethera, vision

The Japanese company Astellas Pharma has acquired British gene therapy group Quethera in a deal worth up to £85 million. …
News
5204602349_c87b204860_z

FDA approves RNA therapy for rare genetic disease

August 13, 2018 Sales and Marketing FDA, Onpattro, Orphan Drugs, RNA, rare diseases

The US Food and Drug Administration has approved the RNA-based therapy Onpattro, for the treatment of the rare genetic disease …
News
abbvie_0

Chicago Judge overturns $140 million AbbVie AndroGel verdict

August 13, 2018 Sales and Marketing AbbVie, Litigation, androgel, legal, testosterone

A US Judge has overturned a $140.1 million verdict against the New York-listed AbbVie Inc. The verdict, which ruled in …
News
fdaoutsideweb

FDA approves first oral therapy for rare Fabry disease

August 13, 2018 Sales and Marketing FDA, Fabry disease, US, pharma

Amicus has revealed that its therapy Galafold (migalastat) has been awarded approval by the FDA in the treatment of adult …
News
nhs_sign

NHS scraps restriction on availability of J&J’s Imbruvica in leukaemia patients

August 10, 2018 Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, NHS, NICE, UK, imbruvica, leukaemia, pharma

The NHS has dropped a controversial restriction preventing leukaemia patients from accessing Johnson & Johnson’s tyrosine kinase inhibitor Imbruvica (ibrutinib), …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10

There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …
News
rep

US Congressman arrested over insider trading in biopharma firm

August 9, 2018 Research and Development, Sales and Marketing Chris Collins, Innate, Innate Immunotherapeutics, US, congress, multiple sclerosis, pharma

A Republican Congressman has been arrested by the FBI over on charges of insider trading with shares in Australian biopharmaceutical …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025